nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—ADRA1B—vas deferens—testicular cancer	0.0928	0.582	CbGeAlD
Pergolide—HTR2A—vein—testicular cancer	0.0143	0.0898	CbGeAlD
Pergolide—DRD4—testis—testicular cancer	0.00676	0.0424	CbGeAlD
Pergolide—DRD5—female gonad—testicular cancer	0.00502	0.0315	CbGeAlD
Pergolide—KCNH2—seminal vesicle—testicular cancer	0.0038	0.0238	CbGeAlD
Pergolide—ADRA2C—seminal vesicle—testicular cancer	0.00375	0.0235	CbGeAlD
Pergolide—ADRA2A—seminal vesicle—testicular cancer	0.00299	0.0188	CbGeAlD
Pergolide—HTR2A—embryo—testicular cancer	0.00271	0.017	CbGeAlD
Pergolide—KCNH2—female gonad—testicular cancer	0.00223	0.014	CbGeAlD
Pergolide—ADRA2C—female gonad—testicular cancer	0.0022	0.0138	CbGeAlD
Pergolide—ADRA2A—gonad—testicular cancer	0.00216	0.0136	CbGeAlD
Pergolide—DRD2—testis—testicular cancer	0.00201	0.0126	CbGeAlD
Pergolide—KCNH2—testis—testicular cancer	0.00198	0.0124	CbGeAlD
Pergolide—ADRA2C—testis—testicular cancer	0.00195	0.0123	CbGeAlD
Pergolide—HTR2A—gonad—testicular cancer	0.00184	0.0115	CbGeAlD
Pergolide—HTR2B—lymph node—testicular cancer	0.0018	0.0113	CbGeAlD
Pergolide—ADRA2A—female gonad—testicular cancer	0.00176	0.011	CbGeAlD
Pergolide—ADRA2A—testis—testicular cancer	0.00156	0.00978	CbGeAlD
Pergolide—KCNH2—lymph node—testicular cancer	0.00144	0.009	CbGeAlD
Pergolide—ADRA2C—lymph node—testicular cancer	0.00142	0.00888	CbGeAlD
Pergolide—CYP2D6—female gonad—testicular cancer	0.00136	0.00854	CbGeAlD
Pergolide—HTR2A—testis—testicular cancer	0.00133	0.00831	CbGeAlD
Pergolide—CYP2D6—testis—testicular cancer	0.00121	0.00757	CbGeAlD
Pergolide—ADRA2A—lymph node—testicular cancer	0.00113	0.00709	CbGeAlD
Pergolide—Eosinophilia—Doxorubicin—testicular cancer	0.000471	0.00056	CcSEcCtD
Pergolide—Sweating—Methotrexate—testicular cancer	0.000469	0.000558	CcSEcCtD
Pergolide—Feeling abnormal—Cisplatin—testicular cancer	0.000469	0.000558	CcSEcCtD
Pergolide—Paraesthesia—Etoposide—testicular cancer	0.000468	0.000557	CcSEcCtD
Pergolide—Weight increased—Epirubicin—testicular cancer	0.000468	0.000556	CcSEcCtD
Pergolide—Pruritus—Ifosfamide—testicular cancer	0.000467	0.000556	CcSEcCtD
Pergolide—Haematuria—Methotrexate—testicular cancer	0.000467	0.000555	CcSEcCtD
Pergolide—Pancreatitis—Doxorubicin—testicular cancer	0.000466	0.000555	CcSEcCtD
Pergolide—Weight decreased—Epirubicin—testicular cancer	0.000465	0.000553	CcSEcCtD
Pergolide—Dyspnoea—Etoposide—testicular cancer	0.000465	0.000553	CcSEcCtD
Pergolide—Hyperglycaemia—Epirubicin—testicular cancer	0.000464	0.000551	CcSEcCtD
Pergolide—Somnolence—Etoposide—testicular cancer	0.000463	0.000551	CcSEcCtD
Pergolide—Angina pectoris—Doxorubicin—testicular cancer	0.000463	0.000551	CcSEcCtD
Pergolide—Epistaxis—Methotrexate—testicular cancer	0.000462	0.000549	CcSEcCtD
Pergolide—Pneumonia—Epirubicin—testicular cancer	0.000461	0.000548	CcSEcCtD
Pergolide—Nausea—Bleomycin—testicular cancer	0.000459	0.000546	CcSEcCtD
Pergolide—Vomiting—Dactinomycin—testicular cancer	0.000458	0.000545	CcSEcCtD
Pergolide—Bronchitis—Doxorubicin—testicular cancer	0.000457	0.000544	CcSEcCtD
Pergolide—Rash—Dactinomycin—testicular cancer	0.000454	0.00054	CcSEcCtD
Pergolide—Decreased appetite—Etoposide—testicular cancer	0.000453	0.000539	CcSEcCtD
Pergolide—Diarrhoea—Ifosfamide—testicular cancer	0.000452	0.000537	CcSEcCtD
Pergolide—Renal failure—Epirubicin—testicular cancer	0.00045	0.000536	CcSEcCtD
Pergolide—Body temperature increased—Cisplatin—testicular cancer	0.00045	0.000535	CcSEcCtD
Pergolide—Neuropathy peripheral—Epirubicin—testicular cancer	0.000449	0.000534	CcSEcCtD
Pergolide—Jaundice—Epirubicin—testicular cancer	0.000447	0.000531	CcSEcCtD
Pergolide—Pain—Etoposide—testicular cancer	0.000446	0.00053	CcSEcCtD
Pergolide—Constipation—Etoposide—testicular cancer	0.000446	0.00053	CcSEcCtD
Pergolide—Conjunctivitis—Epirubicin—testicular cancer	0.000445	0.00053	CcSEcCtD
Pergolide—Urinary tract infection—Epirubicin—testicular cancer	0.000445	0.00053	CcSEcCtD
Pergolide—Dysuria—Doxorubicin—testicular cancer	0.000445	0.000529	CcSEcCtD
Pergolide—Hepatitis—Methotrexate—testicular cancer	0.000439	0.000523	CcSEcCtD
Pergolide—Sweating—Epirubicin—testicular cancer	0.000439	0.000523	CcSEcCtD
Pergolide—Pollakiuria—Doxorubicin—testicular cancer	0.000439	0.000523	CcSEcCtD
Pergolide—Haematuria—Epirubicin—testicular cancer	0.000437	0.00052	CcSEcCtD
Pergolide—Dizziness—Ifosfamide—testicular cancer	0.000436	0.000519	CcSEcCtD
Pergolide—Pharyngitis—Methotrexate—testicular cancer	0.000436	0.000519	CcSEcCtD
Pergolide—Weight increased—Doxorubicin—testicular cancer	0.000433	0.000515	CcSEcCtD
Pergolide—Epistaxis—Epirubicin—testicular cancer	0.000432	0.000514	CcSEcCtD
Pergolide—Weight decreased—Doxorubicin—testicular cancer	0.00043	0.000512	CcSEcCtD
Pergolide—Sinusitis—Epirubicin—testicular cancer	0.00043	0.000511	CcSEcCtD
Pergolide—Feeling abnormal—Etoposide—testicular cancer	0.00043	0.000511	CcSEcCtD
Pergolide—Hyperglycaemia—Doxorubicin—testicular cancer	0.000429	0.00051	CcSEcCtD
Pergolide—Nausea—Dactinomycin—testicular cancer	0.000428	0.000509	CcSEcCtD
Pergolide—Pneumonia—Doxorubicin—testicular cancer	0.000426	0.000507	CcSEcCtD
Pergolide—Gastrointestinal pain—Etoposide—testicular cancer	0.000426	0.000507	CcSEcCtD
Pergolide—Visual impairment—Methotrexate—testicular cancer	0.000424	0.000504	CcSEcCtD
Pergolide—Vomiting—Ifosfamide—testicular cancer	0.00042	0.000499	CcSEcCtD
Pergolide—Bradycardia—Epirubicin—testicular cancer	0.000419	0.000498	CcSEcCtD
Pergolide—Renal failure—Doxorubicin—testicular cancer	0.000417	0.000496	CcSEcCtD
Pergolide—Rash—Ifosfamide—testicular cancer	0.000416	0.000495	CcSEcCtD
Pergolide—Dermatitis—Ifosfamide—testicular cancer	0.000416	0.000495	CcSEcCtD
Pergolide—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000416	0.000494	CcSEcCtD
Pergolide—Jaundice—Doxorubicin—testicular cancer	0.000413	0.000492	CcSEcCtD
Pergolide—Rhinitis—Epirubicin—testicular cancer	0.000412	0.000491	CcSEcCtD
Pergolide—Abdominal pain—Etoposide—testicular cancer	0.000412	0.00049	CcSEcCtD
Pergolide—Body temperature increased—Etoposide—testicular cancer	0.000412	0.00049	CcSEcCtD
Pergolide—Conjunctivitis—Doxorubicin—testicular cancer	0.000412	0.00049	CcSEcCtD
Pergolide—Urinary tract infection—Doxorubicin—testicular cancer	0.000412	0.00049	CcSEcCtD
Pergolide—Hepatitis—Epirubicin—testicular cancer	0.000411	0.000489	CcSEcCtD
Pergolide—Eye disorder—Methotrexate—testicular cancer	0.000411	0.000489	CcSEcCtD
Pergolide—Tinnitus—Methotrexate—testicular cancer	0.00041	0.000488	CcSEcCtD
Pergolide—Asthenia—Cisplatin—testicular cancer	0.000408	0.000486	CcSEcCtD
Pergolide—Pharyngitis—Epirubicin—testicular cancer	0.000408	0.000486	CcSEcCtD
Pergolide—Sweating—Doxorubicin—testicular cancer	0.000406	0.000484	CcSEcCtD
Pergolide—Oedema peripheral—Epirubicin—testicular cancer	0.000405	0.000482	CcSEcCtD
Pergolide—Haematuria—Doxorubicin—testicular cancer	0.000404	0.000481	CcSEcCtD
Pergolide—Epistaxis—Doxorubicin—testicular cancer	0.0004	0.000476	CcSEcCtD
Pergolide—Sinusitis—Doxorubicin—testicular cancer	0.000398	0.000473	CcSEcCtD
Pergolide—Visual impairment—Epirubicin—testicular cancer	0.000396	0.000472	CcSEcCtD
Pergolide—Chills—Methotrexate—testicular cancer	0.000394	0.000469	CcSEcCtD
Pergolide—Nausea—Ifosfamide—testicular cancer	0.000392	0.000466	CcSEcCtD
Pergolide—Diarrhoea—Cisplatin—testicular cancer	0.000389	0.000463	CcSEcCtD
Pergolide—Alopecia—Methotrexate—testicular cancer	0.000388	0.000462	CcSEcCtD
Pergolide—Bradycardia—Doxorubicin—testicular cancer	0.000387	0.000461	CcSEcCtD
Pergolide—Eye disorder—Epirubicin—testicular cancer	0.000384	0.000457	CcSEcCtD
Pergolide—Tinnitus—Epirubicin—testicular cancer	0.000383	0.000456	CcSEcCtD
Pergolide—Rhinitis—Doxorubicin—testicular cancer	0.000382	0.000454	CcSEcCtD
Pergolide—Hepatitis—Doxorubicin—testicular cancer	0.000381	0.000453	CcSEcCtD
Pergolide—Pharyngitis—Doxorubicin—testicular cancer	0.000378	0.000449	CcSEcCtD
Pergolide—Oedema peripheral—Doxorubicin—testicular cancer	0.000375	0.000446	CcSEcCtD
Pergolide—Dysgeusia—Methotrexate—testicular cancer	0.000375	0.000446	CcSEcCtD
Pergolide—Asthenia—Etoposide—testicular cancer	0.000374	0.000445	CcSEcCtD
Pergolide—Back pain—Methotrexate—testicular cancer	0.00037	0.00044	CcSEcCtD
Pergolide—Chills—Epirubicin—testicular cancer	0.000369	0.000439	CcSEcCtD
Pergolide—Pruritus—Etoposide—testicular cancer	0.000369	0.000439	CcSEcCtD
Pergolide—Arrhythmia—Epirubicin—testicular cancer	0.000367	0.000437	CcSEcCtD
Pergolide—Visual impairment—Doxorubicin—testicular cancer	0.000367	0.000436	CcSEcCtD
Pergolide—Alopecia—Epirubicin—testicular cancer	0.000363	0.000432	CcSEcCtD
Pergolide—Vomiting—Cisplatin—testicular cancer	0.000362	0.00043	CcSEcCtD
Pergolide—Rash—Cisplatin—testicular cancer	0.000359	0.000427	CcSEcCtD
Pergolide—Dermatitis—Cisplatin—testicular cancer	0.000358	0.000426	CcSEcCtD
Pergolide—Diarrhoea—Etoposide—testicular cancer	0.000357	0.000424	CcSEcCtD
Pergolide—Eye disorder—Doxorubicin—testicular cancer	0.000356	0.000423	CcSEcCtD
Pergolide—Ill-defined disorder—Methotrexate—testicular cancer	0.000355	0.000422	CcSEcCtD
Pergolide—Tinnitus—Doxorubicin—testicular cancer	0.000355	0.000422	CcSEcCtD
Pergolide—Anaemia—Methotrexate—testicular cancer	0.000354	0.000421	CcSEcCtD
Pergolide—Flatulence—Epirubicin—testicular cancer	0.000353	0.00042	CcSEcCtD
Pergolide—Tension—Epirubicin—testicular cancer	0.000351	0.000418	CcSEcCtD
Pergolide—Dysgeusia—Epirubicin—testicular cancer	0.000351	0.000417	CcSEcCtD
Pergolide—Nervousness—Epirubicin—testicular cancer	0.000348	0.000414	CcSEcCtD
Pergolide—Back pain—Epirubicin—testicular cancer	0.000346	0.000412	CcSEcCtD
Pergolide—Malaise—Methotrexate—testicular cancer	0.000345	0.00041	CcSEcCtD
Pergolide—Dizziness—Etoposide—testicular cancer	0.000345	0.00041	CcSEcCtD
Pergolide—Vertigo—Methotrexate—testicular cancer	0.000344	0.000409	CcSEcCtD
Pergolide—Leukopenia—Methotrexate—testicular cancer	0.000342	0.000407	CcSEcCtD
Pergolide—Chills—Doxorubicin—testicular cancer	0.000341	0.000406	CcSEcCtD
Pergolide—Arrhythmia—Doxorubicin—testicular cancer	0.00034	0.000404	CcSEcCtD
Pergolide—Nausea—Cisplatin—testicular cancer	0.000338	0.000402	CcSEcCtD
Pergolide—Alopecia—Doxorubicin—testicular cancer	0.000336	0.0004	CcSEcCtD
Pergolide—Cough—Methotrexate—testicular cancer	0.000334	0.000397	CcSEcCtD
Pergolide—Ill-defined disorder—Epirubicin—testicular cancer	0.000332	0.000395	CcSEcCtD
Pergolide—Convulsion—Methotrexate—testicular cancer	0.000331	0.000394	CcSEcCtD
Pergolide—Vomiting—Etoposide—testicular cancer	0.000331	0.000394	CcSEcCtD
Pergolide—Anaemia—Epirubicin—testicular cancer	0.000331	0.000394	CcSEcCtD
Pergolide—Agitation—Epirubicin—testicular cancer	0.000329	0.000391	CcSEcCtD
Pergolide—Rash—Etoposide—testicular cancer	0.000329	0.000391	CcSEcCtD
Pergolide—Dermatitis—Etoposide—testicular cancer	0.000328	0.000391	CcSEcCtD
Pergolide—Headache—Etoposide—testicular cancer	0.000327	0.000389	CcSEcCtD
Pergolide—Flatulence—Doxorubicin—testicular cancer	0.000326	0.000388	CcSEcCtD
Pergolide—Chest pain—Methotrexate—testicular cancer	0.000326	0.000388	CcSEcCtD
Pergolide—Arthralgia—Methotrexate—testicular cancer	0.000326	0.000388	CcSEcCtD
Pergolide—Myalgia—Methotrexate—testicular cancer	0.000326	0.000388	CcSEcCtD
Pergolide—Tension—Doxorubicin—testicular cancer	0.000325	0.000387	CcSEcCtD
Pergolide—Dysgeusia—Doxorubicin—testicular cancer	0.000324	0.000386	CcSEcCtD
Pergolide—Malaise—Epirubicin—testicular cancer	0.000323	0.000384	CcSEcCtD
Pergolide—Discomfort—Methotrexate—testicular cancer	0.000322	0.000383	CcSEcCtD
Pergolide—Nervousness—Doxorubicin—testicular cancer	0.000322	0.000383	CcSEcCtD
Pergolide—Vertigo—Epirubicin—testicular cancer	0.000322	0.000383	CcSEcCtD
Pergolide—Syncope—Epirubicin—testicular cancer	0.000321	0.000382	CcSEcCtD
Pergolide—Leukopenia—Epirubicin—testicular cancer	0.00032	0.000381	CcSEcCtD
Pergolide—Back pain—Doxorubicin—testicular cancer	0.00032	0.000381	CcSEcCtD
Pergolide—Palpitations—Epirubicin—testicular cancer	0.000316	0.000376	CcSEcCtD
Pergolide—Confusional state—Methotrexate—testicular cancer	0.000315	0.000375	CcSEcCtD
Pergolide—Loss of consciousness—Epirubicin—testicular cancer	0.000315	0.000374	CcSEcCtD
Pergolide—Cough—Epirubicin—testicular cancer	0.000312	0.000372	CcSEcCtD
Pergolide—Convulsion—Epirubicin—testicular cancer	0.00031	0.000369	CcSEcCtD
Pergolide—Infection—Methotrexate—testicular cancer	0.00031	0.000369	CcSEcCtD
Pergolide—Nausea—Etoposide—testicular cancer	0.00031	0.000368	CcSEcCtD
Pergolide—Hypertension—Epirubicin—testicular cancer	0.000309	0.000368	CcSEcCtD
Pergolide—Ill-defined disorder—Doxorubicin—testicular cancer	0.000307	0.000366	CcSEcCtD
Pergolide—Anaemia—Doxorubicin—testicular cancer	0.000306	0.000364	CcSEcCtD
Pergolide—Thrombocytopenia—Methotrexate—testicular cancer	0.000306	0.000364	CcSEcCtD
Pergolide—Arthralgia—Epirubicin—testicular cancer	0.000305	0.000363	CcSEcCtD
Pergolide—Myalgia—Epirubicin—testicular cancer	0.000305	0.000363	CcSEcCtD
Pergolide—Chest pain—Epirubicin—testicular cancer	0.000305	0.000363	CcSEcCtD
Pergolide—Agitation—Doxorubicin—testicular cancer	0.000304	0.000362	CcSEcCtD
Pergolide—Anxiety—Epirubicin—testicular cancer	0.000304	0.000361	CcSEcCtD
Pergolide—Hyperhidrosis—Methotrexate—testicular cancer	0.000302	0.000359	CcSEcCtD
Pergolide—Discomfort—Epirubicin—testicular cancer	0.000301	0.000358	CcSEcCtD
Pergolide—Malaise—Doxorubicin—testicular cancer	0.000299	0.000355	CcSEcCtD
Pergolide—Dry mouth—Epirubicin—testicular cancer	0.000298	0.000355	CcSEcCtD
Pergolide—Vertigo—Doxorubicin—testicular cancer	0.000298	0.000354	CcSEcCtD
Pergolide—Anorexia—Methotrexate—testicular cancer	0.000298	0.000354	CcSEcCtD
Pergolide—Syncope—Doxorubicin—testicular cancer	0.000297	0.000353	CcSEcCtD
Pergolide—Leukopenia—Doxorubicin—testicular cancer	0.000297	0.000353	CcSEcCtD
Pergolide—Confusional state—Epirubicin—testicular cancer	0.000295	0.000351	CcSEcCtD
Pergolide—Palpitations—Doxorubicin—testicular cancer	0.000293	0.000348	CcSEcCtD
Pergolide—Oedema—Epirubicin—testicular cancer	0.000292	0.000348	CcSEcCtD
Pergolide—Hypotension—Methotrexate—testicular cancer	0.000292	0.000347	CcSEcCtD
Pergolide—Loss of consciousness—Doxorubicin—testicular cancer	0.000291	0.000346	CcSEcCtD
Pergolide—Infection—Epirubicin—testicular cancer	0.00029	0.000345	CcSEcCtD
Pergolide—Cough—Doxorubicin—testicular cancer	0.000289	0.000344	CcSEcCtD
Pergolide—Shock—Epirubicin—testicular cancer	0.000287	0.000342	CcSEcCtD
Pergolide—Convulsion—Doxorubicin—testicular cancer	0.000287	0.000342	CcSEcCtD
Pergolide—Thrombocytopenia—Epirubicin—testicular cancer	0.000286	0.00034	CcSEcCtD
Pergolide—Hypertension—Doxorubicin—testicular cancer	0.000286	0.00034	CcSEcCtD
Pergolide—Tachycardia—Epirubicin—testicular cancer	0.000285	0.000339	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000284	0.000338	CcSEcCtD
Pergolide—Hyperhidrosis—Epirubicin—testicular cancer	0.000282	0.000336	CcSEcCtD
Pergolide—Insomnia—Methotrexate—testicular cancer	0.000282	0.000336	CcSEcCtD
Pergolide—Chest pain—Doxorubicin—testicular cancer	0.000282	0.000336	CcSEcCtD
Pergolide—Arthralgia—Doxorubicin—testicular cancer	0.000282	0.000336	CcSEcCtD
Pergolide—Myalgia—Doxorubicin—testicular cancer	0.000282	0.000336	CcSEcCtD
Pergolide—Anxiety—Doxorubicin—testicular cancer	0.000281	0.000334	CcSEcCtD
Pergolide—Paraesthesia—Methotrexate—testicular cancer	0.00028	0.000334	CcSEcCtD
Pergolide—Discomfort—Doxorubicin—testicular cancer	0.000279	0.000332	CcSEcCtD
Pergolide—Anorexia—Epirubicin—testicular cancer	0.000279	0.000331	CcSEcCtD
Pergolide—Dyspnoea—Methotrexate—testicular cancer	0.000278	0.000331	CcSEcCtD
Pergolide—Somnolence—Methotrexate—testicular cancer	0.000278	0.00033	CcSEcCtD
Pergolide—Dry mouth—Doxorubicin—testicular cancer	0.000276	0.000328	CcSEcCtD
Pergolide—Dyspepsia—Methotrexate—testicular cancer	0.000275	0.000327	CcSEcCtD
Pergolide—Hypotension—Epirubicin—testicular cancer	0.000273	0.000325	CcSEcCtD
Pergolide—Confusional state—Doxorubicin—testicular cancer	0.000273	0.000324	CcSEcCtD
Pergolide—Decreased appetite—Methotrexate—testicular cancer	0.000271	0.000323	CcSEcCtD
Pergolide—Oedema—Doxorubicin—testicular cancer	0.00027	0.000322	CcSEcCtD
Pergolide—Infection—Doxorubicin—testicular cancer	0.000269	0.00032	CcSEcCtD
Pergolide—Pain—Methotrexate—testicular cancer	0.000267	0.000318	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000266	0.000317	CcSEcCtD
Pergolide—Shock—Doxorubicin—testicular cancer	0.000266	0.000316	CcSEcCtD
Pergolide—Thrombocytopenia—Doxorubicin—testicular cancer	0.000265	0.000315	CcSEcCtD
Pergolide—Insomnia—Epirubicin—testicular cancer	0.000264	0.000314	CcSEcCtD
Pergolide—Tachycardia—Doxorubicin—testicular cancer	0.000264	0.000314	CcSEcCtD
Pergolide—Paraesthesia—Epirubicin—testicular cancer	0.000262	0.000312	CcSEcCtD
Pergolide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000261	0.000311	CcSEcCtD
Pergolide—Dyspnoea—Epirubicin—testicular cancer	0.000261	0.00031	CcSEcCtD
Pergolide—Somnolence—Epirubicin—testicular cancer	0.00026	0.000309	CcSEcCtD
Pergolide—Anorexia—Doxorubicin—testicular cancer	0.000258	0.000307	CcSEcCtD
Pergolide—Feeling abnormal—Methotrexate—testicular cancer	0.000257	0.000306	CcSEcCtD
Pergolide—Dyspepsia—Epirubicin—testicular cancer	0.000257	0.000306	CcSEcCtD
Pergolide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000255	0.000304	CcSEcCtD
Pergolide—Decreased appetite—Epirubicin—testicular cancer	0.000254	0.000302	CcSEcCtD
Pergolide—Hypotension—Doxorubicin—testicular cancer	0.000253	0.000301	CcSEcCtD
Pergolide—Pain—Epirubicin—testicular cancer	0.00025	0.000297	CcSEcCtD
Pergolide—Constipation—Epirubicin—testicular cancer	0.00025	0.000297	CcSEcCtD
Pergolide—Abdominal pain—Methotrexate—testicular cancer	0.000247	0.000294	CcSEcCtD
Pergolide—Body temperature increased—Methotrexate—testicular cancer	0.000247	0.000294	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000246	0.000293	CcSEcCtD
Pergolide—Insomnia—Doxorubicin—testicular cancer	0.000245	0.000291	CcSEcCtD
Pergolide—Paraesthesia—Doxorubicin—testicular cancer	0.000243	0.000289	CcSEcCtD
Pergolide—Dyspnoea—Doxorubicin—testicular cancer	0.000241	0.000287	CcSEcCtD
Pergolide—Feeling abnormal—Epirubicin—testicular cancer	0.000241	0.000286	CcSEcCtD
Pergolide—Somnolence—Doxorubicin—testicular cancer	0.00024	0.000286	CcSEcCtD
Pergolide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000239	0.000284	CcSEcCtD
Pergolide—Dyspepsia—Doxorubicin—testicular cancer	0.000238	0.000283	CcSEcCtD
Pergolide—Decreased appetite—Doxorubicin—testicular cancer	0.000235	0.00028	CcSEcCtD
Pergolide—Constipation—Doxorubicin—testicular cancer	0.000231	0.000275	CcSEcCtD
Pergolide—Pain—Doxorubicin—testicular cancer	0.000231	0.000275	CcSEcCtD
Pergolide—Body temperature increased—Epirubicin—testicular cancer	0.000231	0.000275	CcSEcCtD
Pergolide—Abdominal pain—Epirubicin—testicular cancer	0.000231	0.000275	CcSEcCtD
Pergolide—Asthenia—Methotrexate—testicular cancer	0.000224	0.000267	CcSEcCtD
Pergolide—Feeling abnormal—Doxorubicin—testicular cancer	0.000223	0.000265	CcSEcCtD
Pergolide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000221	0.000263	CcSEcCtD
Pergolide—Pruritus—Methotrexate—testicular cancer	0.000221	0.000263	CcSEcCtD
Pergolide—Abdominal pain—Doxorubicin—testicular cancer	0.000214	0.000254	CcSEcCtD
Pergolide—Body temperature increased—Doxorubicin—testicular cancer	0.000214	0.000254	CcSEcCtD
Pergolide—Diarrhoea—Methotrexate—testicular cancer	0.000214	0.000254	CcSEcCtD
Pergolide—Asthenia—Epirubicin—testicular cancer	0.00021	0.000249	CcSEcCtD
Pergolide—Pruritus—Epirubicin—testicular cancer	0.000207	0.000246	CcSEcCtD
Pergolide—Dizziness—Methotrexate—testicular cancer	0.000206	0.000246	CcSEcCtD
Pergolide—Diarrhoea—Epirubicin—testicular cancer	0.0002	0.000238	CcSEcCtD
Pergolide—Vomiting—Methotrexate—testicular cancer	0.000199	0.000236	CcSEcCtD
Pergolide—Rash—Methotrexate—testicular cancer	0.000197	0.000234	CcSEcCtD
Pergolide—Dermatitis—Methotrexate—testicular cancer	0.000197	0.000234	CcSEcCtD
Pergolide—Headache—Methotrexate—testicular cancer	0.000196	0.000233	CcSEcCtD
Pergolide—Asthenia—Doxorubicin—testicular cancer	0.000194	0.000231	CcSEcCtD
Pergolide—Dizziness—Epirubicin—testicular cancer	0.000193	0.00023	CcSEcCtD
Pergolide—Pruritus—Doxorubicin—testicular cancer	0.000191	0.000228	CcSEcCtD
Pergolide—Vomiting—Epirubicin—testicular cancer	0.000186	0.000221	CcSEcCtD
Pergolide—Nausea—Methotrexate—testicular cancer	0.000185	0.000221	CcSEcCtD
Pergolide—Diarrhoea—Doxorubicin—testicular cancer	0.000185	0.00022	CcSEcCtD
Pergolide—Rash—Epirubicin—testicular cancer	0.000184	0.000219	CcSEcCtD
Pergolide—Dermatitis—Epirubicin—testicular cancer	0.000184	0.000219	CcSEcCtD
Pergolide—Headache—Epirubicin—testicular cancer	0.000183	0.000218	CcSEcCtD
Pergolide—Dizziness—Doxorubicin—testicular cancer	0.000179	0.000213	CcSEcCtD
Pergolide—Nausea—Epirubicin—testicular cancer	0.000174	0.000207	CcSEcCtD
Pergolide—Vomiting—Doxorubicin—testicular cancer	0.000172	0.000205	CcSEcCtD
Pergolide—Rash—Doxorubicin—testicular cancer	0.00017	0.000203	CcSEcCtD
Pergolide—Dermatitis—Doxorubicin—testicular cancer	0.00017	0.000203	CcSEcCtD
Pergolide—Headache—Doxorubicin—testicular cancer	0.000169	0.000202	CcSEcCtD
Pergolide—Nausea—Doxorubicin—testicular cancer	0.000161	0.000191	CcSEcCtD
